Beginning on January 27, 2026, DEA said field offices across the US carried out multiple enforcement actions, resulting in the arrest of four individuals, along with the issuance of five Immediate Suspension Orders and one Order to Show Cause against DEA registrants. Investigators allegedly found that operators of the illegal online pharmacies were dispensing and shipping diverted medicines without valid prescriptions to customers across the US, in violation of the Controlled Substances Act, which permits pharmacies to dispense controlled substances only with legitimate prescriptions issued by licensed practitioners.
Over the course of the investigation, the DEA said it identified thousands of customers who had purchased medicines through the websites and sent more than 20,000 letters to the public seeking information to support the ongoing inquiry.
Read more: Emcure Pharma Q3 Results: Strong operating performance but stock gives up gains
“This case demonstrates how foreign-based traffickers exploit our healthcare system, hide behind the internet, and use people inside the US to move dangerous drugs under the guise of legitimate commerce,” said DEA Administrator Terrance Cole.
“Illegal online pharmacies put poison in American communities. They sell counterfeit and unapproved pills and do not care who gets hurt or who dies… If you run these sites, supply them, move the money, ship the product, or help them operate, we will find you, we will dismantle your operations, and we will hold you fully accountable under US law.”
The DEA said it is working with the government of India law enforcement partners to identify and dismantle criminal organisations involved in illegal pharmaceutical trafficking, adding that joint operations will continue to target illicit distributors at source.
The agency also highlighted its 2024 public service warning about illegal online pharmacies, many of which sell counterfeit pills containing fentanyl to unsuspecting customers.
According to the DEA, such sites often use US-based web addresses and professional designs to appear legitimate, while secretly supplying counterfeit or diverted medicines, frequently made with fentanyl or methamphetamine.
Read more: Mankind Pharma Q3 profit rises 7.5% to ₹409 crore as margins stabilise, shares jump nearly 5%
The DEA advised consumers to watch for warning signs such as the sale of prescription drugs without valid prescriptions, unusually low prices, foreign currency listings, missing DEA registration details, damaged packaging, expired medicines, or pills that look different from previous prescriptions.
